ad

SURAKSHA DIAGNOSTIC Q2 Results FY27: Net Profit Jumps 69.31%, Revenue Rs 99.07 Cr, PAT Rs 14.95 Cr

10 Nov 2026 • 11:39 pm

SURAKSHA DIAGNOSTIC Q2 Results FY27: Net Profit Jumps 69.31%, Revenue Rs 99.07 Cr, PAT Rs 14.95 Cr

Quick Answer

SURAKSHA DIAGNOSTIC Q2 Results FY27 were declared on 10 November 2026 on a Consolidated basis. The quarterly results show revenue of Rs 99.07 Cr, up 25.84% YoY from Rs 78.73 Cr, while net profit rose 69.31% YoY to Rs 14.95 Cr from Rs 8.83 Cr. Operating Profit reached Rs 34.81 Cr, and YoY growth in all three lines is the core of the quarter.

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Q2 Results FY27 announced on 10 November 2026, covering the company's financial performance for the July to September quarter. The results date brought consolidated results with revenue of Rs 99.07 Cr and PAT of Rs 14.95 Cr, both higher than a year earlier. Investors following SURAKSHA DIAGNOSTIC Q2 Results FY27 can see revenue up 25.84% and PAT up 69.31% on the same quarter last year.

This results analysis of SURAKSHA DIAGNOSTIC Q2 Results covers the financial highlights, business drivers, outlook and risks behind the numbers. It opens with the Financial Highlights table, which sets this quarter beside the same quarter last year.

Click Here – Get Free Investment Predictions

SURAKSHA DIAGNOSTIC Q2 Results FY27: Financial Highlights

Metric Q2 FY27 (Sep 26) Q2 FY26 (Sep 25) YoY Change
Revenue Rs 99.07 Cr Rs 78.73 Cr +25.84% YoY
Operating Profit Rs 34.81 Cr Rs 24.11 Cr +44.38% YoY
Net Profit (PAT) Rs 14.95 Cr Rs 8.83 Cr +69.31% YoY

Source: company filing for SURAKSHA DIAGNOSTIC Q2 Results FY27, 10 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from SURAKSHA DIAGNOSTIC Q2 Results: What Stands Out

  • Revenue: Rs 99.07 Cr in Q2 against Rs 78.73 Cr a year earlier, a rise of 25.84% on a YoY basis.
  • Net profit: Rs 14.95 Cr versus Rs 8.83 Cr in the comparison quarter, an increase of 69.31% YoY.
  • Operating Profit: Rs 34.81 Cr against Rs 24.11 Cr last year, a gain of 44.38% YoY in SURAKSHA DIAGNOSTIC Q2 Results FY27.
  • Net profit margin: 15.1% in the quarter, up from 11.2% in the comparison quarter.
  • Return on capital employed: 24.97% in FY26, the latest full-year reading alongside the quarter.
  • Next step: The performance analysis shows how revenue, Operating Profit and net profit moved together, and why YoY growth matters.

SURAKSHA DIAGNOSTIC Q2 Results FY27: Performance Analysis

The numbers show revenue and profit both moving up YoY. Revenue reached Rs 99.07 Cr from Rs 78.73 Cr, Operating Profit climbed to Rs 34.81 Cr from Rs 24.11 Cr, and net profit rose to Rs 14.95 Cr from Rs 8.83 Cr in the July to September 2026 quarter.

Profit grew faster than revenue. Revenue added 25.84% YoY, Operating Profit added 44.38% and net profit added 69.31%, so each profit line expanded at a faster pace than the top line. This SURAKSHA DIAGNOSTIC Q2 Results FY27 results analysis shows that gap clearly, and the net profit margin of 15.1% against 11.2% reflects it.

One quarter does not set a trend, so readers of SURAKSHA DIAGNOSTIC Q2 Results will want to see how later filings compare with these figures. The quarterly results also raise a natural question about the business factors disclosed for the quarter, which is where the discussion moves next.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The business factors behind SURAKSHA DIAGNOSTIC Q2 Results FY27 start with revenue, which grew 25.8% year on year to Rs 99.07 Cr in the latest quarter. Revenue is the top line from which the Operating Profit of Rs 34.81 Cr and net profit of Rs 14.95 Cr follow.

Net Profit Margin – Net profit margin improved to 15.1% from 11.2% in the comparison quarter. In these quarterly results, net profit rose 69.3% year on year to Rs 14.95 Cr, which is a faster pace than the revenue increase.

Return on Capital Employed – Return on capital employed was 24.97% in FY26, which gives context to the profit figures above. It is a full-year measure, so it sits alongside the Q2 numbers rather than inside them.

FY27 Outlook After SURAKSHA DIAGNOSTIC Q2 Results

The results analysis for FY27 rests on the Q2 figures already declared. Revenue of Rs 99.07 Cr and net profit of Rs 14.95 Cr are the latest reference points, and full-year FY27 results will depend on the quarters that follow and on disclosed conditions in the business. Reported figures, not forecasts, are the basis here.

For SURAKSHA DIAGNOSTIC Q2 Results FY27, the quarter gives a base of Rs 34.81 Cr in Operating Profit and a 15.1% net profit margin. Readers can follow the next filing on the Univest app and the Univest Screener to see how these figures compare, and the risks below frame what to watch.

Key Risks to Watch After SURAKSHA DIAGNOSTIC Q2 Results FY27

Per-Share Profit Decline

Annual per-share profit has slipped sharply between FY24 and FY26. That annual record sits alongside the higher Q2 figures, so SURAKSHA DIAGNOSTIC Q2 Results FY27 need to be read together with the longer history.

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs 6.28 Cr to Rs 14.95 Cr over the last 5 quarters. The latest figure sits at the top of that range, so the YoY growth of 69.31% should be read against it.

Lower Return on Equity

Return on equity declined to 13.81% in FY26 from 15.93% in FY25. This is an annual measure, so it moves slowly and remains worth tracking in later results.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

SURAKSHA DIAGNOSTIC Q2 Results FY27 show revenue of Rs 99.07 Cr and net profit of Rs 14.95 Cr, both higher YoY. These quarterly results come on a consolidated results basis, and the Univest app can help investors follow the next filing. For SURAKSHA DIAGNOSTIC Q2 Results, readers should consult a SEBI-registered advisor before acting.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions on SURAKSHA DIAGNOSTIC Q2 Results FY27

What are SURAKSHA DIAGNOSTIC Q2 Results FY27?

Ans. SURAKSHA DIAGNOSTIC Q2 Results FY27 cover the July to September 2026 quarter, declared on 10 November 2026, with revenue of Rs 99.07 Cr. Alongside this, net profit was Rs 14.95 Cr, as the Financial Highlights table shows.

What is the results date for SURAKSHA DIAGNOSTIC Q2 Results FY27?

Ans. The results date for SURAKSHA DIAGNOSTIC Q2 Results FY27 is 10 November 2026, when the company declared its Q2 numbers. This results date also frames the Quick Answer and the opening paragraphs, which carry the same figures.

What revenue was reported in SURAKSHA DIAGNOSTIC Q2 Results FY27?

Ans. SURAKSHA DIAGNOSTIC reported revenue of Rs 99.07 Cr, compared with Rs 78.73 Cr a year earlier, so growth was 25.84% YoY. This links to the Performance Analysis section, where revenue is read against profit.

What net profit was reported in SURAKSHA DIAGNOSTIC Q2 Results FY27?

Ans. Net profit of Rs 14.95 Cr was reported for SURAKSHA DIAGNOSTIC, against Rs 8.83 Cr a year earlier, a rise of 69.31%. The Key Takeaways section places this net profit beside the margin of 15.1%.

How much YoY growth did revenue show in SURAKSHA DIAGNOSTIC Q2 Results FY27?

Ans. Revenue grew 25.84% YoY, moving from Rs 78.73 Cr to Rs 99.07 Cr in the quarter. This YoY growth is covered in the Performance Analysis section, alongside Operating Profit and net profit.

Did net profit rise or fall in SURAKSHA DIAGNOSTIC Q2 Results?

Ans. Net profit rose in SURAKSHA DIAGNOSTIC Q2 Results, up 69.31% YoY to Rs 14.95 Cr from Rs 8.83 Cr. That rise outpaced revenue, so the Key Business Factors section links it to the margin of 15.1%.

What was the Operating Profit in SURAKSHA DIAGNOSTIC Q2 Results FY27?

Ans. Operating Profit in SURAKSHA DIAGNOSTIC Q2 Results FY27 was Rs 34.81 Cr against Rs 24.11 Cr a year earlier, a rise of 44.38% YoY. Compared with revenue growth of 25.84%, this is covered in the Performance Analysis.

Are SURAKSHA DIAGNOSTIC Q2 Results consolidated results or standalone results?

Ans. Yes, SURAKSHA DIAGNOSTIC Q2 Results are consolidated results, as the company reported on a Consolidated basis. This means the figures follow the consolidated statement, and the Quick Answer states the basis alongside the results date.

What business factors shaped SURAKSHA DIAGNOSTIC Q2 Results FY27?

Ans. Revenue growth of 25.8%, a net profit margin of 15.1% against 11.2%, and return on capital employed of 24.97% in FY26 are the business factors listed for the quarter. The Key Business Factors section explains each one.

What are the key risks after SURAKSHA DIAGNOSTIC Q2 Results FY27?

Ans. The key risks are a sharp annual decline in per-share profit, volatile quarterly net profit between Rs 6.28 Cr and Rs 14.95 Cr, and return on equity of 13.81% in FY26. The Key Risks section covers each one.

What is the outlook after SURAKSHA DIAGNOSTIC Q2 Results?

Ans. SURAKSHA DIAGNOSTIC Q2 Results give a base for FY27, with revenue of Rs 99.07 Cr and net profit of Rs 14.95 Cr. Full-year FY27 results will depend on later quarters, as the Outlook section explains.

Where can I find the complete SURAKSHA DIAGNOSTIC Q2 Results FY27 data?

Ans. The complete SURAKSHA DIAGNOSTIC Q2 Results FY27 data can be followed on the Univest app and the Univest Screener, while this article covers the main figures. The Financial Highlights table lists revenue, Operating Profit and net profit side by side.


Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down